Psychedelic Drugs Market with COVID-19 Impact Analysis, by Drug Type (Ketamine, Gamma Hydroxybutyric Acid (GHB), Lysergic Acid Diethylamide (LSD), Psilocybin, 3,4-MethylEnedioxyMethamphetamine, and Other Drug Types), By Application (Opiate Addiction, Treatment-Resistant Depression, Narcolepsy, Post-traumatic Stress Disorder, and Panic Disorder, Other Applications), By Distribution Channel (Retail Pharmacy, Hospital Pharmacy, and Online Distribution Channel), By Country, and By Region Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
REPORT HIGHLIGHT
Psychedelic Drugs Market size was valued at USD 4,870.12 Million in 2022, expanding at a CAGR of 13.46% from 2023 to 2030.
Drugs known as \"psychedelics\" have the power to significantly change perception, cognition, and mood while bringing on intense sensory experiences and possibly life-changing revelations. Among these are drugs like psilocybin mushrooms, DMT, and LSD. They can cause hallucinations, strong emotions, and altered states of consciousness by acting on brain receptors. Although these chemicals have been studied for therapeutic and spiritual reasons, using them comes with hazards, such as negative side effects and psychological difficulties.
Psychedelic Drugs Market- Market Dynamics
- Increasing awareness about the importance of addressing mental health concerns
The market\'s expansion is significantly influenced by the requirement for managing excessive stress, anxiety, and other mental illnesses. Some therapies for mental illness have shown promise due to the novel pathways offered by psychedelic substances, while others have failed. Over the course of the projection period, it is predicted that government efforts, partnerships, and awareness campaigns related to mental health will fuel market expansion. For instance, over the past 22 years, the Mental Health Foundation has chosen the theme, planned, and sponsored Mental Health Awareness Week. During this period, the event has expanded to become one of the most significant awareness weeks both in the UK and around the world.
Psychedelic Drugs Market- Key Insights
- As per the analysis shared by our research analyst, the global Psychedelic Drugs market is estimated to grow annually at a CAGR of around 13.46% over the forecast period (2023-2030)
- The Psychedelic Drugs industry is projected to grow at a significant rate due to the increasing awareness about the importance of addressing mental health concerns
- Based on Drug Type segmentation, psilocybin was predicted to show maximum market share in the year 2022
- Based on application segmentation, Treatment-Resistant Depression was the leading type in 2022
- Based on distribution segmentation, hospital was the leading type in 2022
- On the basis of region, North America was the leading revenue generator in 2022
Psychedelic Drugs Market- Segmentation Analysis:
The Global Psychedelic Drugs Market is segmented on the basis of Drug Type, Application, Technology, and Region.
The market is divided into categories based on Drug Type: Ketamine, Gamma Hydroxybutyric Acid (GHB), Lysergic Acid Diethylamide (LSD), Psilocybin, 3,4-MethylEnedioxyMethamphetamine, and Other Drug Types. The market is dominated by psilocybin. Clinical studies including psilocybin have been conducted for illnesses including addiction, anxiety, depression, and end-of-life suffering. The preliminary findings have demonstrated positive effects, sparking interest and funding for the creation of psilocybin-based treatments.
The market is divided into categories based on distribution: Retail Pharmacy, Hospital Pharmacy, and Online Distribution Channel. Due to factors such as rising public awareness of mental disorders, the need for prescriptions for psychedelic drugs from a doctor, and the use of these drugs for specific signs that are fueling the expansion of pharmacies in hospitals as distribution channels, the hospital drug store segment is predicted to grow over the forecast period.
Psychedelic Drugs Market- Geographical Insights
Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. Due to increased psychedelic research and development, rising public awareness of the need to treat mental disorders, and rising incidence and prevalence of mental disorder issues, North America is predicted to account for a significant share of the global market for psychedelic drugs.
Psychedelic Drugs Market- Competitive Landscape:
Companies sell their products through a variety of channels, including corporate websites, e-commerce websites, retailers, distributors, and end consumers. Products makers compete on a variety of aspects, including product costs, performance, product making, technology, reputation, and availability. Some of the primary techniques used by corporations to strengthen their reach and expand their market share include new product launches, distribution network development, R&D spending, and mergers and acquisitions. For instance, in October 2022, Numinus Wellness Inc., a psychological care firm promoting novel treatments and safe, based on evidence psychedelic-assisted treatments, launched its Ketamine for Serious and Chronic Medical Illness Program. It\'s probable that Numinus\' clinics in British Columbia, Utah, and Quebec will be the first to implement this new approach.
Recent Developments:
- In March 2022, University of California researchers published the findings and follow-up information from a phase 3 clinical trial using the psychedelic substance 3,4-methylenedioxymethamphetamine (MDMA) in conjunction with psychotherapy to treat post-traumatic stress disorder (PTSD). Their preliminary findings showed that the therapy is effective even for people who are difficult to treat, such those who have drug or alcohol use problems.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL PSYCHEDELIC DRUGS MARKET KEY PLAYERS
- Silo Wellness
- Revive Therapeutics
- PsyBio Therapeutics
- Numinus Wellness
- Mydecine Innovations Group
- MindMed
- MagicMed Industries
- Field Trip Health
- Entheon Biomedical
- Eleusis Ltd.
- Cybin Inc.
- Compass Pathways
- Bright Minds Biosciences
- Beckley Psytech
- Atai Life Sciences
GLOBAL PSYCHEDELIC DRUGS MARKET, BY DRUG TYPE
- Ketamine
- Gamma Hydroxybutyric Acid (GHB)
- Lysergic Acid Diethylamide (LSD)
- Psilocybin
- 3,4-MethylEnedioxyMethamphetamine
- Other Drug Types
GLOBAL PSYCHEDELIC DRUGS MARKET, BY APPLICATION
- Opiate Addiction
- Treatment-Resistant Depression
- Narcolepsy
- Post-traumatic Stress Disorder
- Panic Disorder
- Others Applications
GLOBAL PSYCHEDELIC DRUGS MARKET, BY DISTRIBUTION
- Retail Pharmacy
- Hospital Pharmacy
- Online Distribution Channel
GLOBAL PSYCHEDELIC DRUGS MARKET, BY REGION
- North America
- The U.S.
- Canada
- Europe
- Germany
- France
- Italy
- Spain
- United Kingdom
- Russia
- Netherlands
- Sweden
- Poland
- Rest of Europe
- Asia Pacific
- India
- China
- South Korea
- Japan
- Australia
- Thailand
- Indonesia
- Philippines
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
- The Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
TABLE OF CONTENT
1. Psychedelic Drugs Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Psychedelic Drugs Market Snippet by Drug Type
2.1.2. Psychedelic Drugs Market Snippet by Application
2.1.3. Psychedelic Drugs Market Snippet by Distribution
2.1.4. Psychedelic Drugs Market Snippet by Country
2.1.5. Psychedelic Drugs Market Snippet by Region
2.2. Competitive Insights
3. Psychedelic Drugs Key Market Trends
3.1. Psychedelic Drugs Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Psychedelic Drugs Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Psychedelic Drugs Market Opportunities
3.4. Psychedelic Drugs Market Future Trends
4. Psychedelic Drugs Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Psychedelic Drugs Market: COVID-19 Impact Analysis
5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
5.2.1. Top Performing Segments
5.2.2. Marginal Growth Segments
5.2.3. Top Looser Segments
5.2.4. Marginal Loss Segments
6. Psychedelic Drugs Market Landscape
6.1. Psychedelic Drugs Market Share Analysis, 2022
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Psychedelic Drugs Market – By Drug Type
7.1. Overview
7.1.1. Segment Share Analysis, By Drug Type, 2022 & 2030 (%)
7.1.2. Ketamine
7.1.3. Gamma Hydroxybutyric Acid (GHB)
7.1.4. Lysergic Acid Diethylamide (LSD)
7.1.5. Psilocybin
7.1.6. 3,4-MethylEnedioxyMethamphetamine
7.1.7. Other Drug Types
8. Psychedelic Drugs Market – By Application
8.1. Overview
8.1.1. Segment Share Analysis, By Application, 2022 & 2030 (%)
8.1.2. Opiate Addiction
8.1.3. Treatment-Resistant Depression
8.1.4. Narcolepsy
8.1.5. Post-traumatic Stress Disorder
8.1.6. Panic Disorder
8.1.7. Others Applications
9. Psychedelic Drugs Market – By Distribution
9.1. Overview
9.1.1. Segment Share Analysis, By Distribution, 2022 & 2030 (%)
9.1.2. Retail Pharmacy
9.1.3. Hospital Pharmacy
9.1.4. Online Distribution Channel
10. Psychedelic Drugs Market– By Geography
10.1. Introduction
10.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
10.2. North America
10.2.1. Overview
10.2.2. Psychedelic Drugs Key Manufacturers in North America
10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
10.2.4. North America Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
10.2.5. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.2.6. North America Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
10.2.7. U.S.
10.2.7.1. Overview
10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.2.7.3. U.S. Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
10.2.7.4. U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.2.7.5. U.S. Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
10.2.8. Canada
10.2.8.1. Overview
10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.2.8.3. Canada Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
10.2.8.4. Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.2.8.5. Canada Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
10.3. Europe
10.3.1. Overview
10.3.2. Psychedelic Drugs Key Manufacturers in Europe
10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
10.3.4. Europe Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
10.3.5. Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.3.6. Europe Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
10.3.7. Germany
10.3.7.1. Overview
10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.7.3. Germany Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
10.3.7.4. Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.3.7.5. Germany Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
10.3.8. Italy
10.3.8.1. Overview
10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.8.3. Italy Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
10.3.8.4. Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.3.8.5. Italy Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
10.3.9. United Kingdom
10.3.9.1. Overview
10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.9.3. United Kingdom Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
10.3.9.4. United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.3.9.5. United Kingdom Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
10.3.10. France
10.3.10.1. Overview
10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.10.3. France Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
10.3.10.4. France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.3.10.5. France Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
10.3.11. Russia
10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.11.2. Russia Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
10.3.11.3. Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.3.11.4. Russia Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
10.3.12. Netherlands
10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.12.2. Netherlands Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
10.3.12.3. Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.3.12.4. Netherlands Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
10.3.13. Sweden
10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.13.2. Sweden Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
10.3.13.3. Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.3.13.4. Sweden Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
10.3.14. Poland
10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.14.2. Poland Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
10.3.14.3. Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.3.14.4. Poland Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
10.3.15. Rest of Europe
10.3.15.1. Overview
10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.15.3. Rest of the Europe Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
10.3.15.4. Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.3.15.5. Rest of the Europe Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
10.4. Asia Pacific (APAC)
10.4.1. Overview
10.4.2. Psychedelic Drugs Key Manufacturers in Asia Pacific
10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
10.4.4. Asia Pacific Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
10.4.5. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.4.6. Asia Pacific Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
10.4.7. India
10.4.7.1. Overview
10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.7.3. India Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
10.4.7.4. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.4.7.5. India Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
10.4.8. China
10.4.8.1. Overview
10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.8.3. China Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
10.4.8.4. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.4.8.5. China Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
10.4.9. Japan
10.4.9.1. Overview
10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.9.3. Japan Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
10.4.9.4. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.4.9.5. Japan Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
10.4.10. South Korea
10.4.10.1. Overview
10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.10.3. South Korea Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
10.4.10.4. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.4.10.5. South Korea Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
10.4.11. Australia
10.4.11.1. Overview
10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.11.3. Australia Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
10.4.11.4. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.4.11.5. Australia Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
10.4.12. Thailand
10.4.12.1. Overview
10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.12.3. Thailand Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
10.4.12.4. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.4.12.5. Thailand Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
10.4.13. Indonesia
10.4.13.1. Overview
10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.13.3. Indonesia Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
10.4.13.4. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.4.13.5. Indonesia Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
10.4.14. Philippines
10.4.14.1. Overview
10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.14.3. Philippines Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
10.4.14.4. Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.4.14.5. Philippines Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
10.4.15. Rest of APAC
10.4.15.1. Overview
10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.15.3. Rest of APAC Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.4.15.5. Rest of APAC Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
10.5. Latin America
10.5.1. Overview
10.5.2. Psychedelic Drugs Key Manufacturers in Latin America
10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
10.5.4. Latin America Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
10.5.5. Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.5.6. Latin America Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
10.5.7. Brazil
10.5.7.1. Overview
10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.5.7.3. Brazil Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
10.5.7.4. Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.5.7.5. Brazil Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
10.5.8. Mexico
10.5.8.1. Overview
10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.5.8.3. Mexico Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
10.5.8.4. Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.5.8.5. Mexico Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
10.5.9. Argentina
10.5.9.1. Overview
10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.5.9.3. Argentina Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
10.5.9.4. Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.5.9.5. Argentina Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
10.5.10. Colombia
10.5.10.1. Overview
10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.5.10.3. Colombia Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
10.5.10.4. Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.5.10.5. Colombia Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
10.5.11. Rest of LATAM
10.5.11.1. Overview
10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.5.11.3. Rest of LATAM Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.5.11.5. Rest of LATAM Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
10.6. Middle East and Africa
10.6.1. Overview
10.6.2. Psychedelic Drugs Key Manufacturers in Middle East and Africa
10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
10.6.4. Middle East and Africa Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
10.6.5. Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.6.6. Middle East and Africa Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
10.6.7. Saudi Arabia
10.6.7.1. Overview
10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.7.3. Saudi Arabia Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.6.7.5. Saudi Arabia Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
10.6.8. United Arab Emirates
10.6.8.1. Overview
10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.8.3. United Arab Emirates Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
10.6.8.4. United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.6.8.5. United Arab Emirates Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
10.6.9. Israel
10.6.9.1. Overview
10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.9.3. Israel Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
10.6.9.4. Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.6.9.5. Israel Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
10.6.10. Turkey
10.6.10.1. Overview
10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.10.3. Turkey Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
10.6.10.4. Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.6.10.5. Turkey Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
10.6.11. Algeria
10.6.11.1. Overview
10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.11.3. Algeria Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
10.6.11.4. Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.6.11.5. Algeria Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
10.6.12. Egypt
10.6.12.1. Overview
10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.12.3. Egypt Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
10.6.12.4. Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.6.12.5. Egypt Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
10.6.13. Rest of MEA
10.6.13.1. Overview
10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.13.3. Rest of MEA Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.6.13.5. Rest of MEA Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
11. Key Vendor Analysis- Psychedelic Drugs Industry
11.1. Competitive Dashboard
11.2. Company Profiles
11.2.1. Silo Wellness
11.2.2. Revive Therapeutics
11.2.3. PsyBio Therapeutics
11.2.4. Numinus Wellness
11.2.5. Mydecine Innovations Group
11.2.6. MindMed
11.2.7. MagicMed Industries
11.2.8. Field Trip Health
11.2.9. Entheon Biomedical
11.2.10. Eleusis Ltd.
11.2.11. Cybin Inc.
11.2.12. Compass Pathways
11.2.13. Bright Minds Biosciences
11.2.14. Beckley Psytech
11.2.15. Atai Life Sciences
12. 360 Degree Analyst View
13. Appendix
13.1. Research Methodology
13.2. References
13.3. Abbreviations
13.4. Disclaimer
13.5. Contact Us
